DNMT1 silencing increases the expression of RASSF1A and DAPK in ESCC cells and decreases the methylation of both promoters, thereby inhibiting ESCC cell proliferation and invasion [158]. Here, DAPK1 is linked to esophageal squamous cell carcinoma.